Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN005415 | 63.0288 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 71.4948 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 98.9617 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 98.9837 | 8.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 98.9840 | 4.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 99.0281 | 4.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 99.0442 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 100.0758 | 3.25 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 100.1124 | 12.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 101.0148 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0336 | 9.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0340 | 17.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0340 | 19.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0460 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0468 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0529 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0551 | 1.33 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 102.0554 | 0.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 103.0546 | 1.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 103.1235 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 103.1546 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 103.2350 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 103.5103 | 4.23 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.0092 | 5.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.0092 | 5.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.0093 | 4.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.0310 | 1.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.0783 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.1068 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.1071 | 16.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.5180 | 4.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 104.5807 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0330 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0332 | 15.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0333 | 8.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0338 | 14.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0456 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.0703 | 16.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.5263 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 105.9554 | 19.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 106.0322 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 106.0373 | 14.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.0258 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.0496 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.0703 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.0708 | 17.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.5415 | 3.9 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 107.9608 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 108.0283 | 7.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 108.0285 | 5.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 108.5308 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 109.0647 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 109.0651 | 6.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 109.0652 | 1.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 109.0654 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 109.0882 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 110.0348 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 110.0611 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 110.0778 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 110.1130 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 111.0808 | 6.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 111.0808 | 6.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 111.5257 | 3.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.0071 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.0508 | 1.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.0598 | 10.25 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.0765 | 0.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.1119 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.5915 | 0.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 112.8961 | 0.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0292 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0346 | 1.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0419 | 16.46 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0420 | 14.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0601 | 4.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0712 | 12.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0712 | 16.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0713 | 12.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.0715 | 13.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.1326 | 19.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.1330 | 18.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 113.5382 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0370 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0371 | 9.02 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0373 | 6.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0374 | 6.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0377 | 7.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0410 | 0.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0544 | 10.3 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0656 | 0.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0742 | 0.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 114.0915 | 4.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 115.9987 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 116.0294 | 5.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 116.0698 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 116.1775 | 4.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 116.5184 | 6.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 116.5194 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.0577 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.0655 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.0690 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.5352 | 4.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.5496 | 4.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 117.9976 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.0265 | 10.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.0652 | 15.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.0744 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.0862 | 1.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.0864 | 0.94 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.1729 | 4.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.1732 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 118.5345 | 7.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0354 | 1.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0355 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0355 | 4.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0486 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0494 | 11.93 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0854 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0855 | 2.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0857 | 1.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.0858 | 14.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.5412 | 4.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.5856 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 119.9938 | 9.14 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0035 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0220 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0450 | 5.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0485 | 11.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0807 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.0833 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.1895 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.2201 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.2448 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.2779 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.3365 | 3.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.5310 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.5312 | 3.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.5314 | 10.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 120.5322 | 7.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0301 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0304 | 19.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0572 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0616 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0647 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0861 | 7.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0897 | 12.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.0913 | 13.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.1015 | 18.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 121.5280 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0256 | 6.18 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0258 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0283 | 9.02 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0610 | 6.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0611 | 11.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 122.0966 | 2.93 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0411 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0444 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0552 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0788 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0800 | 6.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0800 | 6.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0810 | 7.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0813 | 9.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.0815 | 10.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.1650 | 1.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 123.5364 | 1.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 124.5077 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 124.5330 | 6.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 124.5339 | 6.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 124.5573 | 7.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 124.5697 | 12.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0045 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0322 | 4.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0326 | 4.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0586 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0601 | 5.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0613 | 6.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0621 | 1.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.0938 | 6.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.5231 | 5.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.5235 | 5.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.5417 | 6.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.5421 | 9.23 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 125.5426 | 9.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.0978 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.0978 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.0985 | 9.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.1866 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5312 | 5.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5312 | 5.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5492 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5495 | 8.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5495 | 10.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.5496 | 10.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 126.9891 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.0120 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.0389 | 4.23 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.0394 | 0.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.0397 | 2.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.0413 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.1234 | 3.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.1235 | 3.78 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 127.5396 | 12.58 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0482 | 4.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0534 | 7.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0618 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0628 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0629 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0635 | 13.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0667 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0676 | 2.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0690 | 2.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0696 | 2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0702 | 0.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0709 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.0881 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.1073 | 3.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.1074 | 7.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.5031 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.5235 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.5417 | 7.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.6048 | 3.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.9509 | 0.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 128.9510 | 3.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0424 | 1.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0444 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0558 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0589 | 4.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0669 | 2.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0692 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0693 | 13.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.0697 | 13.38 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 129.1386 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.0498 | 1.3 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.0498 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.0613 | 5.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.0865 | 6.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.0866 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5253 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5254 | 1.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5257 | 2.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5257 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5258 | 2.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5258 | 4.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5258 | 5.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5258 | 6.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5259 | 3.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5259 | 3.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5259 | 3.78 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5259 | 4.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5259 | 6.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 130.5329 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 131.5064 | 8.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 131.5326 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 131.5769 | 13.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 131.5903 | 18.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0050 | 0.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0475 | 9.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0476 | 11.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0478 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0478 | 8.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0480 | 5.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0481 | 8.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0481 | 18.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0482 | 14.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0483 | 12.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0484 | 10.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0486 | 6.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0486 | 12.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0490 | 17.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0575 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.0772 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.1016 | 2.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.1617 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.2526 | 6.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.5475 | 6.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.5493 | 10.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.5500 | 9.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 132.9870 | 0.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.0315 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.0619 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.0874 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.0957 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.0980 | 16.07 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.4623 | 9.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.5387 | 5.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 133.9753 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0188 | 9.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0190 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0272 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0527 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0967 | 5.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.0969 | 9.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.5468 | 10.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.5470 | 10.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 134.5488 | 8.46 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0037 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0162 | 5.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0293 | 1.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0311 | 2.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0456 | 5.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.0804 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.1165 | 18.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.1169 | 18.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.5273 | 14.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 135.5544 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0223 | 18.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0226 | 8.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0226 | 10.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0226 | 18.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0227 | 18.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0254 | 19.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0388 | 1.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.0755 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.1125 | 16.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.1774 | 2.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.1779 | 1.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.2697 | 2.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.5121 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 136.6023 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.0313 | 6.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.0458 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.0595 | 8.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.0595 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.0707 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.1617 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.1620 | 1.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.2546 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.5233 | 9.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.5235 | 7.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 137.9682 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0281 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0282 | 8.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0284 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0324 | 6.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0542 | 0.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.0916 | 3.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.5329 | 7.17 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.5678 | 11.42 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.9072 | 0.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 138.9934 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0506 | 4.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0542 | 8.19 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0549 | 18.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0755 | 6.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0759 | 6.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0759 | 6.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.0978 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 139.5794 | 11.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0688 | 4.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0689 | 3.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0696 | 3.07 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0701 | 5.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0718 | 6.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0801 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.0893 | 14.86 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.1072 | 12.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.4944 | 2.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.5635 | 12.17 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.5637 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.5647 | 13.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 140.9043 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0439 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0521 | 8.46 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0575 | 4.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0624 | 4.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0677 | 0.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0700 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.0702 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.1153 | 7.29 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.1386 | 4.19 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.1393 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.5542 | 12.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.5544 | 11.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.5545 | 10.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.5546 | 11.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.5713 | 11.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.9401 | 0.8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 141.9847 | 4.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0326 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0358 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0414 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0517 | 6.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0619 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0622 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0648 | 14.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0650 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.0662 | 4.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 142.1514 | 12.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0709 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0725 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0731 | 3.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0735 | 5.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0810 | 0.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0840 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0855 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.0900 | 15.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.5570 | 15.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 143.9982 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0106 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0213 | 19.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0427 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0481 | 2.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0493 | 7.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0806 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.0809 | 5.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.1021 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.1021 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.1388 | 14.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.1999 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.2948 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 144.4983 | 8.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0178 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0193 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0335 | 6.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0359 | 7.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0359 | 9.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0359 | 9.97 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0361 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0363 | 7.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0364 | 8.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0364 | 9.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0383 | 3.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0453 | 0.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0456 | 2.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.0651 | 15.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.5384 | 8.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.5968 | 4.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.6075 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 145.9749 | 0.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.0267 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.0270 | 0.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.0630 | 3.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.0778 | 8.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.0925 | 1.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.1173 | 0.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.1652 | 0.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.1799 | 4.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.4804 | 13.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.5288 | 5.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.5656 | 12.8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 146.5733 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0300 | 13.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0318 | 6.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0318 | 14.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0320 | 12.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0324 | 12.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0325 | 11.75 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0328 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0329 | 11.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0332 | 10.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0336 | 10.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0437 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0590 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0620 | 8.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0655 | 19.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0777 | 15.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.0820 | 17.02 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.1131 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.1132 | 6.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.1165 | 16.94 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.4832 | 11.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.5721 | 11.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 147.6083 | 17.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0252 | 10.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0256 | 7.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0523 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0571 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0668 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.0787 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.1105 | 13.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.1144 | 0.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.1734 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.5392 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.5619 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.5622 | 12.58 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.5623 | 11.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 148.9615 | 0.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0231 | 19.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0240 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0242 | 1.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0242 | 16.75 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0261 | 18 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0263 | 17.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0507 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0508 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0525 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0593 | 8.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0597 | 10.86 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0599 | 14.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0601 | 15.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0602 | 16.19 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0664 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0703 | 9.97 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.0853 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.2778 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.5249 | 14.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.5338 | 5.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 149.5573 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0141 | 0.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0494 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0583 | 12.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0594 | 4.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0608 | 15.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0798 | 14.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.0917 | 7.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.1273 | 15.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.1280 | 19.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.1281 | 17.86 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.1282 | 15.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 150.1284 | 15.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.0352 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.0655 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.0967 | 17.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.0972 | 17.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.0974 | 15.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.1491 | 11.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5171 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5173 | 9.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5173 | 10.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5420 | 11.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5425 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.5499 | 3.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.6075 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 151.9493 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0166 | 9.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0167 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0346 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0374 | 9.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0481 | 4.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0566 | 2.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0604 | 14.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.0613 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 152.5475 | 7.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.0199 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.0530 | 19.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.0702 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.5463 | 8.29 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.5734 | 13.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.9486 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 153.9940 | 2.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0209 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0397 | 1.25 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0658 | 4.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0735 | 15.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0797 | 1.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0843 | 2.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0859 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0873 | 7.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.0977 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.1060 | 16.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.1226 | 7.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.5622 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.5711 | 12.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.5755 | 19.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 154.9697 | 1.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.0465 | 8.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.0688 | 2.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.0708 | 18.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.0840 | 15.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.1179 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.1545 | 4.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.1551 | 0.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.5695 | 11.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.5697 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.5699 | 12.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.9769 | 13.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 155.9938 | 16.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0115 | 12.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0151 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0188 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0673 | 11.54 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0675 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0721 | 11.9 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0768 | 0.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0768 | 5.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0806 | 4.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.0810 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.5325 | 11.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.5604 | 11.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.5669 | 14.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.5768 | 12.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 156.6181 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.0253 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.0597 | 3.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.0780 | 9.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.0835 | 4.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.0838 | 3.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.1037 | 17.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.1223 | 11.54 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.1340 | 7.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.5077 | 12.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 157.5495 | 7.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0045 | 6.23 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0346 | 3.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0355 | 7.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0607 | 2.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0796 | 8.19 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0931 | 1.59 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.0957 | 3.13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.1165 | 6.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.1542 | 11.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.1649 | 0.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.5285 | 9.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.9640 | 0.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 158.9659 | 12.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.0277 | 2.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.0353 | 6.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.0353 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.0918 | 7.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.0946 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.1128 | 2.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.1157 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.5056 | 10.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.5058 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.6085 | 16.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.9707 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 159.9919 | 6.18 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0351 | 11.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0362 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0428 | 9.02 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0434 | 11.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0747 | 10.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0756 | 3.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.0901 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.1121 | 10.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.1338 | 1.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.1680 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.1680 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.1683 | 6.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.2682 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.2683 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.5624 | 13.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.6029 | 14.86 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.6164 | 17.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 160.9735 | 0.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0185 | 2.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0464 | 6.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0466 | 7.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0482 | 9.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0802 | 12.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.0965 | 8.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.5342 | 8.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.5630 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 161.5811 | 19.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.0232 | 1.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.0569 | 3.93 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.0845 | 11.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.0904 | 4.29 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.0918 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.1124 | 0.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.5288 | 1.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.5772 | 13.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.5776 | 14.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.5859 | 10.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 162.9903 | 18.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0391 | 9.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0393 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0394 | 16.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0409 | 5.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0441 | 1.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0634 | 4.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0644 | 3.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0668 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0750 | 14.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0752 | 8.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0754 | 15.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0758 | 16.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0769 | 14.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.0779 | 10.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.5398 | 7.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.5634 | 9.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.5673 | 8.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.5675 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.6031 | 14.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 163.6038 | 15.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.0293 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.0457 | 9.97 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.0660 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.0948 | 16.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.1131 | 17.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 164.1270 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0497 | 12.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0544 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0636 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0713 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0721 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0728 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0751 | 16.19 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0790 | 3.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.0889 | 6.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.1823 | 1.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.1826 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.9523 | 0.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 165.9810 | 10.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.0703 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.0865 | 14.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.0870 | 14.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.0914 | 17.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1227 | 7.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1227 | 8.07 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1228 | 8.75 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1228 | 15.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1229 | 9.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1231 | 5.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1231 | 13.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.1358 | 16.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.2141 | 3.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.3163 | 3.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.5545 | 2.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 166.5861 | 13.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.0575 | 2.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.0778 | 12.8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.0854 | 14.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.0882 | 15.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.1552 | 3.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.4922 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.4944 | 11.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.5700 | 12.1 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.5967 | 16.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.6020 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 167.9940 | 9.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0728 | 5.59 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0788 | 6.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0806 | 4.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0818 | 14.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0836 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.0846 | 9.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.1215 | 17.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.1219 | 17.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.1387 | 9.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.1388 | 8.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5020 | 13.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5107 | 10.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5425 | 6.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5927 | 13.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5950 | 13.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 168.5999 | 4.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0172 | 4.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0339 | 6.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0466 | 16.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0473 | 15.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0586 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0611 | 3.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0736 | 1.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0736 | 1.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0777 | 5.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0785 | 5.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0842 | 4.09 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0852 | 7.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0854 | 7.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0854 | 8.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0858 | 10.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0860 | 6.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0861 | 9.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0864 | 18.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0914 | 13.58 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.0949 | 0.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.4920 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.5217 | 8.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.5834 | 15.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.5853 | 13.75 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.5853 | 15.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.6302 | 17.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.9782 | 8.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.9784 | 0.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 169.9864 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0135 | 11.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0566 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0586 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0712 | 4.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0947 | 6.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0948 | 6.73 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.0967 | 13.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.1049 | 1.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.1053 | 1.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.1174 | 8.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.1418 | 8.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.2106 | 1.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.5666 | 1.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.5753 | 10.55 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.5938 | 14.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 170.9924 | 3.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0027 | 9.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0038 | 10.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0600 | 9.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0631 | 3.67 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0633 | 3.17 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.0994 | 5.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.1021 | 9.59 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.1022 | 11.42 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.1160 | 16.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.2789 | 8.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.5906 | 0.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 171.6312 | 17.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0301 | 10.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0305 | 9.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0425 | 9.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0732 | 7.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0750 | 5.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0751 | 5.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.0885 | 8.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1023 | 17.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1105 | 16.54 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1157 | 18.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1684 | 15.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1694 | 12.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1696 | 12.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.1796 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.5218 | 12.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 172.5515 | 9.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0329 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0782 | 2.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0793 | 15.3 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0793 | 16.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0805 | 5.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.0897 | 12.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.1283 | 3.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.1284 | 3.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.1553 | 8.51 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.2093 | 2.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.2591 | 3.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.2593 | 3.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.5182 | 8.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.5224 | 1.39 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.5744 | 13.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 173.6420 | 17.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0229 | 5.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0352 | 4.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0389 | 1.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0572 | 7.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0579 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0605 | 0.74 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0791 | 2.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0871 | 3.9 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0894 | 15.3 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.0907 | 8.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.5335 | 1.6 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.5586 | 8.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.6158 | 16.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.6316 | 19.26 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.9386 | 0.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.9935 | 1.35 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 174.9986 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0026 | 9.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0343 | 5.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0345 | 5.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0411 | 12.49 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0450 | 18.52 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0461 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0635 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0639 | 9.02 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0656 | 14.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0757 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0814 | 6.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.0842 | 0.64 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.1187 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.4808 | 11.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.5391 | 13.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.5690 | 12.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.5999 | 19.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.6003 | 16.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.6016 | 15.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.6024 | 16.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 175.6028 | 16.08 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0386 | 1.93 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0555 | 5.04 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0699 | 7.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0713 | 6.95 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0744 | 4.61 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0744 | 11.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0749 | 4.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0773 | 13.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.0950 | 8 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.1036 | 16.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.1225 | 17.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.1435 | 8.41 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.1438 | 12.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.2020 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.3074 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.4918 | 11.78 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 176.9930 | 13.36 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0092 | 19.21 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0094 | 17.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0096 | 18.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0098 | 17.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0099 | 18.66 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0460 | 9.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0460 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0906 | 11.56 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0918 | 14.5 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0921 | 15.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.0938 | 18.14 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1003 | 4.82 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1011 | 5.4 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1207 | 18.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1636 | 18.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1638 | 18.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.1646 | 15.3 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.4804 | 11.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.5564 | 14.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.5650 | 9.97 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.6192 | 17.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9581 | 1.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9581 | 3.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9581 | 3.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9582 | 5.28 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9856 | 0.96 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 177.9858 | 1.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.0884 | 14.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.1060 | 18.14 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.1099 | 17.34 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.1225 | 11.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.1234 | 9.14 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.1288 | 18.84 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.5550 | 10.03 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.5646 | 0.92 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.5806 | 12.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 178.6204 | 17.06 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0486 | 1.37 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0641 | 6.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0650 | 11.83 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0651 | 2.78 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0667 | 10.57 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0674 | 17.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0681 | 19.91 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0922 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.0948 | 5.79 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.1526 | 10.25 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.4778 | 11.78 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.5174 | 5.18 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.5524 | 3.58 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.5529 | 3.07 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 179.5704 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0040 | 0.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0191 | 10.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0192 | 10.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0197 | 11.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0376 | 3.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0420 | 19.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0510 | 8.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0839 | 15.01 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0860 | 13.11 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0879 | 3.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0969 | 14.33 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.0972 | 0.69 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.1022 | 1.81 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.1025 | 9.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.1158 | 16.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.1386 | 10.27 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.1523 | 11.22 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.4764 | 11.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.6102 | 15.33 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.6143 | 17.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 180.9804 | 11.85 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0738 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0774 | 2.76 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0817 | 13.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0852 | 14.62 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0852 | 15.45 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0868 | 18.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0904 | 16.43 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.0985 | 17.12 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.1081 | 1.32 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.1473 | 10.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.1703 | 6.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.1704 | 8.97 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 181.7960 | 3.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0241 | 9.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0395 | 5.53 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0708 | 8.31 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0778 | 9.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0781 | 14.77 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0810 | 1.98 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0819 | 0.89 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0908 | 0.65 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.0950 | 6.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.1181 | 7.59 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.1201 | 17.68 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.1373 | 18.99 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.1912 | 7.05 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.2152 | 1.71 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.5937 | 18.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.6033 | 16.88 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 182.9641 | 0.72 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0631 | 3.44 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0658 | 0.87 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0710 | 12.48 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0824 | 12.7 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0878 | 13 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0928 | 4.38 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.0985 | 9.24 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.1000 | 18.16 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.1002 | 9.47 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.1032 | 16.15 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.1863 | 6.2 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.5153 | 8.63 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.5467 | 3.29 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.5640 | 16.59 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells | |
| AN005415 | 183.5934 | 14.29 | Minutes | ST003305 | POSITIVE | Waters Xevo-G2-XS | Reversed phase | Human | Cancer cells |
